Advertising Litigation: Laws, Claims, and Defense Strategies

Advertising litigation covers legal actions involving claims made in commercial advertising across any channel: product labels, websites, broadcast media, and social media. Most cases fit one of three patterns: a false or misleading statement of fact, a failure to substantiate health or performance claims before publication, or noncompliance with rules specific to a regulated industry. Each pattern involves different evidentiary burdens and can proceed in federal court, state court, or before the FTC.

The Lanham Act §43(a) (15 U.S.C. §1125(a)) gives any business the right to sue a competitor whose commercial advertising contains a false or misleading statement of fact likely to cause consumer confusion or commercial injury. A competing company with a commercial interest in the relevant market has standing to bring a federal claim without being a consumer. Lanham Act suits proceed in federal court and can yield injunctive relief, damages, and attorney fees.

The Federal Trade Commission enforces Section 5 of the FTC Act (15 U.S.C. §45), which prohibits unfair or deceptive acts and practices. Section 5 does not give private parties a right of action; only the FTC can initiate proceedings under it. A Section 5 violation can result in consent orders, civil penalties, and mandatory corrective advertising.

New York consumers and businesses also have state law remedies. Under consumer protection law, New York GBL §349 prohibits deceptive acts and practices broadly, while GBL §350 targets false advertising specifically. Both statutes give individual consumers a private right of action for actual damages, and a plaintiff does not need to prove that the advertiser intended to deceive.

• The defendant made a false or misleading statement of fact in commercial advertising or promotion.
• The statement deceived or was likely to deceive a substantial portion of the intended audience.
• The deception was material, meaning it was likely to influence purchasing decisions.
• The defendant placed the statement in interstate commerce.
• The plaintiff suffered or is likely to suffer commercial injury as a result.

Courts evaluate express claims, those asserting a specific verifiable fact, as literally true or false. Implied claims require survey evidence showing that consumers drew a false conclusion from the ad, even when each individual statement was technically accurate. The false advertising law standards for both types are covered in a companion guide.

A statement qualifies as puffery when it is too vague to measure objectively. Courts have consistently held that superlatives such as "the best coffee in New York" fall outside the Lanham Act because no reasonable consumer treats them as objective statements of fact. Literal truth works differently: a technically accurate statement can still support a false advertising claim if it creates a misleading overall impression for the target audience, so defendants should examine the full campaign context rather than the disputed sentence in isolation.

Truthful comparative advertising using verified data is lawful under federal and New York law. The protection disappears when comparisons are accurate in isolation but selectively framed to distort the full picture. The First Amendment may protect purely political or social commentary about an industry, but courts apply a narrower analysis to commercial speech, and this defense rarely succeeds in a straightforward product claim dispute.

"Reasonable basis" typically means competent and reliable scientific evidence for health and performance claims. A company that publishes an efficacy claim without adequate documentation faces FTC enforcement risk even when no consumer has filed a complaint. Advertisers who retain a substantiation file for each claim can respond to both FTC inquiries and Lanham Act demand letters far more efficiently. Building an advertising compliance program around this requirement reduces enforcement exposure across all marketing channels.

Four sectors face heightened FTC scrutiny beyond the general substantiation standard:

• Health and pharmaceutical: Efficacy claims require controlled clinical trials or recognized scientific consensus, not consumer testimonials alone.
• Financial services: Interest rate, fee, and return disclosures must be clear and conspicuous; the Consumer Financial Protection Bureau coordinates with the FTC on financial product marketing.
• Environmental marketing: The FTC's Green Guides set thresholds for terms such as "recyclable," "biodegradable," and "carbon neutral." Vague environmental claims regularly draw enforcement action.
• Influencer and social media: Any material connection between a brand and an endorser requires a clear disclosure at the start of each sponsored post or video.

Parties submit consumer surveys to show what message the target audience actually took from an ad. Courts scrutinize survey methodology carefully, and inadequate controls reduce a survey's evidentiary weight significantly. Both sides typically retain survey experts, and deposing those experts is often a decisive phase of the case.

Courts can order the defendant to stop running the challenged ad immediately, require corrective advertising, or award the plaintiff its lost profits, the defendant's attributable profits, or corrective advertising costs. Injunctive relief is usually the primary goal because monetary damages are genuinely difficult to quantify; many advertising cases resolve at the preliminary injunction stage rather than proceeding to a damages trial.

Every objective claim in a campaign should have a substantiation file before the ad runs, including the underlying data, studies, or expert opinions supporting the claim. A company with organized records can respond to an FTC inquiry or a Lanham Act demand letter far more efficiently than one reconstructing documentation after the fact.

Legal review at the copy approval stage catches claims that cross from puffery into verifiable fact, missing FTC required disclosures, and comparisons that existing data cannot support. Competitor monitoring, a systematic review of rival advertising against legal standards, can also surface grounds for a Lanham Act injunction when a competitor's false claims are diverting customers. Our advertising and marketing law team advises on both compliance programs and enforcement strategy.